Traverse 2025 Testosterone. There has been longstanding concern that testosterone replacement therapy may increase cardiovascular risk, as well as the risk of thromboembolic disease. The traverse trial was done with topical testosterone.

1 university of washington school of medicine, seattle, wa 98195, usa. May 27, 2025 39 comments.